Teladoc Health (NYSE: TDOC) has announced a pharmacy integration agreement with Eli Lilly’s LillyDirect pharmacy partner, Gifthealth, aimed at streamlining access to Zepbound® (tirzepatide) for Teladoc Health members enrolled in its Comprehensive Weight Care Program.
This collaboration ensures that eligible patients without insurance coverage for GLP-1s can receive affordable, safe, and effective weight-loss medication. Through LillyDirect, prescribed Zepbound® will be delivered directly to patients’ homes in single-use vials.
Keep Reading
Add A Comment